Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
Go back to Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program| (NASDAQ: DTIL) | Delayed: 6.71 +0.15 (2.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.56 | 52 Week High | $ | |||
| Open | $6.62 | 52 Week Low | $ | |||
| Day High | $6.86 | P/E | N/A | |||
| Day Low | $6.55 | EPS | $ | |||
| Volume | 231,041 | |||||



